Search

Search Constraints

You searched for: Author/Creator Jansen, Willemijn J.

Search Results

3. A synergistic association of diabetes and AD biomarkers on cognitive decline in persons without dementia?. (20th December 2022)

4. Amyloid‐ß aggregation, APOE‐e genotype, and the trajectory of cognitive decline in persons without dementia. (20th December 2022)

5. Associations of AD risk factors with cerebrospinal fluid ATN biomarker profiles in 10, 662 persons without dementia from the Amyloid Biomarker Study. (20th December 2022)

6. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. (19th May 2018)

7. Characteristics of subjective cognitive decline associated with amyloid positivity. Issue 10 (8th December 2021)

8. CSF amyloid‐beta, tau, and neurodegenerative and inflammatory biomarkers in cognitively unimpaired late middle‐aged and older adult APOE ε4 homozygotes, heterozygotes, and non‐carriers from the Arizona APOE Cohort. (31st December 2021)

10. F4‐02‐02: The influence of severity of total comorbidity on cognitive decline and conversion to dementia in memory clinic visitors. (1st July 2015)